Bank Of Montreal Biogen Inc. Put Options Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 02, 2023	SELL	$275.25 - $318.06 $24.8 Million - $28.6 Million	-90,000 Reduced 78.26%	25,000 $7.12 Million
Q1 2023 Jun 13, 2024	BUY	$256.56 - $292.34 $6.41 Million - $7.31 Million	25,000 New	25,000 $6.95 Million
Q4 2022 Feb 01, 2023	BUY	$252.44 - $306.72 $3.66 Million - $4.45 Million	14,500 Added 14.43%	115,000 $31.8 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $19.6 Million - $27 Million	100,500 New	100,500 $27.2 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $503,802 - $634,764	2,600 New	2,600 $637,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.